ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,466Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1211

$1.21M Total Retail Price of All Prescriptions

Rank: 12 out of 1211

1,231 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 18,589 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METOPROLOL SUCCINATE 1,803 1,747 10 1 5
AMLODIPINE BESYLATE 1,052 1,014 2 2
CRESTOR 986 903 3 11
DIOVAN 757 738 4 21
CARVEDILOL 750 710 5 3
ATENOLOL 734 686 6 13
DIGOXIN 636 616 7 15
SIMVASTATIN 583 551 8 1
CLOPIDOGREL 551 516 9 10
FUROSEMIDE 547 518 10 7
DIOVAN HCT 474 456 11 35
PLAVIX 440 425 12 14
ATORVASTATIN CALCIUM 434 409 13 9
METOPROLOL TARTRATE 419 405 14 4
LISINOPRIL 370 352 15 6
WARFARIN SODIUM 338 338 16 8
BENICAR HCT 329 315 17 78
AMLODIPINE BESYLATE-BENAZEPRIL 317 301 18 46
BENICAR 297 285 19 69
EXFORGE 250 250 20 87
AZOR 249 243 21 142
LOSARTAN POTASSIUM 213 207 22 12
OMEPRAZOLE 203 200 23 20
BYSTOLIC 202 201 24 36
POTASSIUM CHLORIDE 179 158 25 19
ZOLPIDEM TARTRATE 178 167 26 32
XARELTO 155 154 27 61
ISOSORBIDE MONONITRATE ER 148 136 28 16
HYDROCHLOROTHIAZIDE 143 133 29 17
CILOSTAZOL 142 113 30 83
PRAVASTATIN SODIUM 138 138 31 18
AMIODARONE HCL 135 135 32 30
PRADAXA 130 130 33 23
DOXAZOSIN MESYLATE 129 120 34 48
COREG CR 128 110 35 145
ALPRAZOLAM 125 125 36 54
NITROSTAT 115 113 37 26
ENALAPRIL MALEATE 112 98 38 28
CLONIDINE HCL 103 97 39 34
RANITIDINE HCL 101 88 40 45
NEXIUM 100 95 41 41
TRICOR 100 83 41 82
NIFEDIPINE ER 97 81 43 43
VALSARTAN-HYDROCHLOROTHIAZIDE 87 82 44 182
PANTOPRAZOLE SODIUM 85 82 45 44
VERAPAMIL ER 85 85 45 77
FENOFIBRATE 84 80 47 42
LOSARTAN-HYDROCHLOROTHIAZIDE 83 83 48 29
RANEXA 83 83 48 40
LIPITOR 79 74 50 38
DILTIAZEM ER 77 77 51 123
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 74 52 39
METFORMIN HCL 74 74 52 27
PENTOXIFYLLINE 74 74 52 152
TOPROL XL 73 68 55 154
LOVAZA 71 71 56 52
LANSOPRAZOLE 64 64 57 127
LOVASTATIN 62 62 58 37
BENAZEPRIL HCL 56 56 59 85
KLOR-CON 10 55 55 60 93
TRIBENZOR 54 53 61 176
TRILIPIX 53 48 62 139
TEKTURNA 52 52 63 162
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.